Protocol Ledger

NCT03593759 · Phase III · RECRUITING

Cardiac Sarcoidosis Randomized Trial

Interventional Phase III clinical trial protocol NCT03593759 sponsored by Ottawa Heart Institute Research in Cardiovascular and Thrombosis, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2019-01-15 Enrollment: 160 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT03593759
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)160 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)4 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT03593759
Protocol FieldVerified Registry Value
NCT IdentifierNCT03593759
Consolidated Lead SponsorOttawa Heart Institute Research
Therapeutic Condition CohortCardiovascular and Thrombosis
Clinical Trial PhasePhase III
Overall Recruitment StatusRECRUITING
Registered Enrollment160 participants (ESTIMATED)
Registered Start Date2019-01-15
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Search related sites and sponsors in the Interactive Directory, explore Cardiovascular and Thrombosis Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI